<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Biswas S</submitter><funding>NCI NIH HHS</funding><pagination>517-25</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4157068</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>84(3)</volume><pubmed_abstract>Doxorubicin-loaded PEGylated liposomes (commercially available as DOXIL or Lipodox) were surface functionalized with a cell-penetrating peptide, octa-arginine (R8). For this purpose, R8-peptide was conjugated to the polyethylene glycol-dioleoyl phosphatidylethanolamine (PEG-DOPE) amphiphilic co-polymer. The resultant R8-PEG-PE conjugate was introduced into the lipid bilayer of liposomes at 2 mol% of total lipid amount via spontaneous micelle-transfer technique. The liposomal modification did not alter the particle size distribution, as measured by Particle Size Analyzer and transmission electron microscopy (TEM). However, surface-associated cationic peptide increased zeta potential of the modified liposomes. R8-functionalized liposomes (R8-Dox-L) markedly increased the intracellular and in</pubmed_abstract><journal>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</journal><pubmed_title>Surface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activity.</pubmed_title><pmcid>PMC4157068</pmcid><funding_grant_id>R01 CA 128486</funding_grant_id><funding_grant_id>R01 CA121838</funding_grant_id><funding_grant_id>R01 CA128486</funding_grant_id><pubmed_authors>Deshpande PP</pubmed_authors><pubmed_authors>Biswas S</pubmed_authors><pubmed_authors>Dodwadkar NS</pubmed_authors><pubmed_authors>Parab S</pubmed_authors><pubmed_authors>Torchilin VP</pubmed_authors></additional><is_claimable>false</is_claimable><name>Surface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activity.</name><description>Doxorubicin-loaded PEGylated liposomes (commercially available as DOXIL or Lipodox) were surface functionalized with a cell-penetrating peptide, octa-arginine (R8). For this purpose, R8-peptide was conjugated to the polyethylene glycol-dioleoyl phosphatidylethanolamine (PEG-DOPE) amphiphilic co-polymer. The resultant R8-PEG-PE conjugate was introduced into the lipid bilayer of liposomes at 2 mol% of total lipid amount via spontaneous micelle-transfer technique. The liposomal modification did not alter the particle size distribution, as measured by Particle Size Analyzer and transmission electron microscopy (TEM). However, surface-associated cationic peptide increased zeta potential of the modified liposomes. R8-functionalized liposomes (R8-Dox-L) markedly increased the intracellular and in</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Aug</publication><modification>2025-04-19T08:54:56.37Z</modification><creation>2019-03-27T01:35:20Z</creation></dates><accession>S-EPMC4157068</accession><cross_references><pubmed>23333899</pubmed><doi>10.1016/j.ejpb.2012.12.021</doi></cross_references></HashMap>